Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 15;27(12):e147.
doi: 10.1093/ibd/izab159.

Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis

Molly L Stone  1 , Erin M Forster  2
Affiliations

Use of Vedolizumab in Immune Checkpoint Inhibitor-associated Enterocolitis

Molly L Stone et al. Inflamm Bowel Dis. .
No abstract available

Keywords: checkpoint-inhibitor enterocolitis; pembrolizumab; vedolizumab.

PubMed Disclaimer

References

    1. Dougan M, Wang Y, Rubio-Tapia A, et al. AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review. Gastroenterology. 2021;160:1384–1393. - PubMed
    1. Lukin DJWA, Aniwan S, Kadire S, et al. Comparative safety profile of vedolizumab and tumor necrosis factor-antagonist therapy for inflammatory bowel disease: a multicenter consortium propensity score-matched analysis. Gastroenterology. 2018;154:S68.
    1. Abu-Sbeih H, Ali FS, Alsaadi D, et al. Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. J Immunother Cancer. 2018;6:142. - PMC - PubMed
    1. Johnson DH, Zobniw CM, Trinh VA, et al. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. J Immunother Cancer. 2018;6:103. - PMC - PubMed

MeSH terms

Substances